Last reviewed · How we verify
Influenza challenge virus
Influenza challenge virus is a Biologic drug developed by Imperial College London. It is currently in Phase 1 development.
At a glance
| Generic name | Influenza challenge virus |
|---|---|
| Sponsor | Imperial College London |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Influenza Human Challenge Model (PHASE1)
- Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza (PHASE1)
- BPL-1357 Against H1N1 Influenza Virus Challenge (PHASE2)
- pH1N1 Blinded Challenge Study (PHASE1)
- A/Texas Flu Challenge (PHASE1)
- Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness (PHASE1)
- Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain (PHASE1)
- Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenza challenge virus CI brief — competitive landscape report
- Influenza challenge virus updates RSS · CI watch RSS
- Imperial College London portfolio CI
Frequently asked questions about Influenza challenge virus
What is Influenza challenge virus?
Influenza challenge virus is a Biologic drug developed by Imperial College London.
Who makes Influenza challenge virus?
Influenza challenge virus is developed by Imperial College London (see full Imperial College London pipeline at /company/imperial-college-london).
What development phase is Influenza challenge virus in?
Influenza challenge virus is in Phase 1.
Related
- Manufacturer: Imperial College London — full pipeline
- Compare: Influenza challenge virus vs similar drugs
- Pricing: Influenza challenge virus cost, discount & access